Institut Bordet - Retour à la page d'accueil
en
I want to donate to research

 News

The Jules Bordet Institute opens its Radiotheranostics Centre of Excellence

Press release (28/04/2022)  The Jules Bordet Institute opens its Radiotheranostics Centre of Excellence A new era in treating and diagnosing patients in Nuclear Medicine 28 April 2022 – Wednesday 27 April 2022, the Jules Bordet Institute officially opened its "Radiotheranostics Centre of Excellence" in its Department of Nuclear Medicine. An innovative form of targeted drug therapy in fighting cancer, radiotheranostics is today a…
(read more)

Covid-19 informations

Visits to patients are allowed subject to certain conditions. Persons accompanying out-patients (consultations and technical medical procedures) are allowed CLICK HERE FOR MORE INFORMATION
(read more)

The RESTART programme

News (03/03/2022) The RESTART programme: personalised follow-up for persons with breast cancer in remission.   The RESTART programme offers patients with breast cancer in remission a multidisciplinary and personalised follow-up that combines consultations, physical activities, physiotherapy and educational workshops. The first patients joined the project at the beginning of January 2022 and have participated in the first…
(read more)

Objective 20 KM

News : 14/02/2022 25 patients at the Jules Bordet Institute accompanied by care staff will be taking up the challenge and competing in the Brussels 20 km. 

Who said that cancer and sport are incompatible? Certainly not us!  Discover the project  
(read more)

PAtient CEntricity Award de la Belgian Hematology Society

News (07/02/2022) The Jules Bordet Institute Hematology Department honoured with PAtient CEntricity Award from the Belgian Hematology Society. This Saturday 5 February 2022, the Institute's Hematology Department was honoured with the PACE Award and a grant of 10 000 euros for its project for a multidisciplinary approach to managing pain caused by drugs administered to treat multiple myeloma.


Dr. Marie Vercruyssen, hematologist…
(read more)

4 February = World Cancer Day

Press release (04/02/2022)  4 February = World Cancer Day DECRESCENDO, a new large clinical trial to test a less intensive chemotherapy treatment for patients with HER2-positive breast cancer Brussels (Belgium), 4 February 2022 - A new international clinical study was recently
opened in France and Belgium – with the first patient enrolled on 17 January – to assess
if it is possible to give a less intensive chemotherapy…
(read more)

Best Wishes 2022 !

The new Jules Bordet Institute presents its best wishes for 2022!
Together may we continue to rise to new challenges and make further progress in the fight against cancer.
(read more)

Une équipe d’expérience pour diriger l’Hôpital Universitaire de Bruxelles (H.U.B)

Actualité du 15/12/2021 Une équipe d’expérience pour diriger l’Hôpital Universitaire de Bruxelles (H.U.B) Le Conseil d’administration de l’H.U.B a désigné Renaud Witmeur et le Professeur Jean-Michel Hougardy respectivement comme Directeur Général et Directeur Général Médical de l’Hôpital Universitaire de Bruxelles (H.U.B). L’H.U.B regroupe l’Hôpital Erasme, l’Institut Jules Bordet et l’Hôpital Universitaire des Enfants Reine Fabiola (…
(read more)

De kerstmarkt

The Christmas Market in the Institut Jules Bordet

News : 08/12/2021 The Christmas Market is coming to the New Jules Bordet Institute! Sunday 12 and Monday 13 December from 12 noon to 6 pm the central aisle of the New Institute will be ready to welcome the Christmas Market complete with Christmas lights and decorations! Delicacies, handicrafts and many other great ideas for gifts will be on display.  All profits will go to the Jules Bordet Association and the Wellbeing Fund for…
(read more)

Movember 2021

08/11/2021 The Jules Bordet Institute lends its full support to the international Movember campaign that every year alerts public opinion to male cancers and raises funds for research into such male diseases as prostate cancer.  There is no mistaking the figures: Prostrate cancer is the second most common cancer after breast cancer with more than 10,000 new cases recorded every year in Belgium. It cannot be stressed enough that …
(read more)